Technology | Radiation Dose Management | September 07, 2017

September 7, 2017 — Sapheneia and Scannerside received U.S. Food and Drug Administration (FDA) 510(k) clearance to...

FDA Holds MIDAC Meeting on Gadolinium-Based Contrast Agents. Image by Marilyn Fornell
News | Contrast Media | September 07, 2017

September 7, 2017 — The U.S. Food and Drug Administration (FDA) announced it would hold a meeting of the Medical...

LAA closure during open heart surgery in the LAACS Study showed better outcomes for all patients.

LAA closure during open heart surgery in the LAACS Study showed better outcomes for all patients.

Feature | Left Atrial Appendage (LAA) Occluders | September 07, 2017

September 7, 2017 — Closure of the left atrial appendage (LAA) during heart surgery protects the brain, according to...

Giving oxygen to patients suffering a heart attack is not beneficial, according to the DETO2X-AMI study.

Giving oxygen to patients suffering a heart attack is not beneficial, according to the DETO2X-AMI study presented at ESC 2017.

Feature | ESC | September 07, 2017

September 7, 2017 — Oxygen therapy does not improve survival in patients with heart attack symptoms, according to...

PURE study may cause revision of fat intake guidelines for cardiology.
Feature | ESC | September 07, 2017

September 7, 2017 — Researchers at the European Society of Cardiology (ESC) Congress called for a reconsideration of...

Florida Medical Center First in State to Offer High Sensitive STAT Blood Test
News | Blood Testing | September 07, 2017

September 7, 2017 — In July, The Heart Institute at Florida Medical Center became the first hospital in the state of...

Protembis Announces Successful First-in-Human Use of  ProtEmbo Cerebral Protection System in European Trial
News | Embolic Protection Devices | September 07, 2017

September 7, 2017 — Protembis GmbH announced the first clinical applications of its ProtEmbo Cerebral Protection...

Siemens Healthineers Receives FDA Clearance for TrueFusion Structural Heart Disease Feature
Technology | Cardiovascular Ultrasound | September 06, 2017

September 6, 2017 — The U.S. Food and Drug Administration (FDA) has cleared TrueFusion, a new cardiovascular...

Heart Failure Patients, Clinicians Have Differing Perceptions of Risk Level
News | Heart Failure | September 06, 2017

September 6, 2017 — Physicians identified a majority of patients with advanced...

Text Messaging Could Help Tackle High Blood Pressure in At-Risk Patients

Image courtesy of Michigan Medicine

News | Hypertension | September 06, 2017

September 6, 2017 — A new National Institutes of Health-funded...

Minneapolis Heart Institute Foundation Enrolls First Patient in TRILUMINATE Tricuspid Repair Trial
News | Heart Valve Technology | September 05, 2017

September 5, 2017 — Minneapolis Heart Institute Foundation announced it has enrolled the first-in-the-world patient...

Israeli Hospital Completes First Implant of CORolla Heart Failure Device
News | Heart Failure | September 05, 2017

September 5, 2017 — Rambam Hospital in Haifa, Israel, recently became the first to use the CORolla device from...

Abbott Initiates U.S. Pivotal Study of Amplatzer Device for Patent Ductus Arteriosus
News | Congenital Heart | September 05, 2017

September 5, 2017 — Abbott announced it has initiated a U.S. pivotal clinical study evaluating the safety and...

EMANATE Trial Shows Apixaban Lowers stroke in AF Patients Undergoing Cardioversion.
News | Atrial Fibrillation | September 01, 2017

September 1, 2017 — Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with...

CASTLE-AF Study shows Catheter Ablation of Atrial Fibrillation is First-Line Treatment for Heart Failure Patients. Biotronic Ilivia 7 ICD.

The CASTLE-AF Study shows catheter alation of AF can be used effectively to treat heart failure in patients with an implanted ICD.

News | Atrial Fibrillation | September 01, 2017

September 1, 2017 — Final results from the CASTLE-AF study show a 38 percent reduction in the composite of all-cause...

Overlay Init